Pharmacist participation in stroke response cuts door-to-needle time

Pharmacist participation in stroke response cuts door➜Needle time

(HealthDay)—Having a pharmacist at bedside during acute ischemic stroke is associated with significantly shorter door-to-needle (DTN) times, according to a study published recently in the Annals of Pharmacotherapy.

Megan A. Rech, Pharm.D., from the Loyola Medical Center in Maywood, Ill., and colleagues conducted a to examine whether presence at bedside during acute ischemic stroke correlated with a reduction in DTN times. Data were included for 125 patients who received recombinant ; 45 and 80 patients had and did not have a pharmacist present (PharmD and no-PharmD groups, respectively).

The researchers found that the median DTN time was significantly shorter in the PharmD group versus the no-PharmD group (48 versus 73 minutes; P < 0.01). Overall, 71 and 29 percent of patients in the PharmD and no-PharmD groups met the goal of DTN ≤60 minutes (P < 0.01). The only factor independently associated with reduction in DTN time was pharmacist at the bedside (β coefficient, −23.5 minutes).

"These findings support the inclusion of a stroke-competent pharmacist in the bedside response team for patients," the authors write.


Explore further

Follow-up delta CHA2DS2-VASc score better predicts CVA in A-fib

More information: Abstract/Full Text (subscription or payment may be required)
Journal information: Annals of Pharmacotherapy

Copyright © 2018 HealthDay. All rights reserved.

Citation: Pharmacist participation in stroke response cuts door-to-needle time (2018, January 19) retrieved 28 January 2020 from https://medicalxpress.com/news/2018-01-pharmacist-response-door-to-needle.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
200 shares

Feedback to editors

User comments